Fatal drug trial raises questions about 'informed consent'
D000047:Academies and Institutes; D032962:Consent Forms; D016638:Critical Illness; D003643:Death; D030881:Disclosure; D064420:Drug-Related Side Effects and Adverse Reactions; D015507:Drugs, Investigational; D035082:Federal Government; D006076:Government; D006505:Hepatitis; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent; D008099:Liver; D009026:Mortality; D009316:National Institutes of Health (U.S.); D016134:Organizational Policy; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D014481:United States
Biomedical and Behavioral Research; National Institutes of Health; Popular Approach/Source